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Abstract
Emerging evidence suggests that connexin mediated gap junctional intercellular communication contributes to many
aspects of bone biology including bone development, maintenance of bone homeostasis and responsiveness of bone cells
to diverse extracellular signals. Deletion of connexin 43, the predominant gap junction protein in bone, is embryonic lethal
making it challenging to examine the role of connexin 43 in bone in vivo. However, transgenic murine models in which only
osteocytes and osteoblasts are deficient in connexin 43, and which are fully viable, have recently been developed.
Unfortunately, the bone phenotype of different connexin 43 deficient models has been variable. To address this issue, we
used an osteocalcin driven Cre-lox system to create osteoblast and osteocyte specific connexin 43 deficient mice. These
mice displayed bone loss as a result of increased bone resorption and osteoclastogenesis. The mechanism underlying this
increased osteoclastogenesis included increases in the osteocytic, but not osteoblastic, RANKL/OPG ratio. Previous in vitro
studies suggest that connexin 43 deficient bone cells are less responsive to biomechanical signals. Interestingly, and in
contrast to in vitro studies, we found that connexin 43 deficient mice displayed an enhanced anabolic response to
mechanical load. Our results suggest that transient inhibition of connexin 43 expression and gap junctional intercellular
communication may prove a potentially powerful means of enhancing the anabolic response of bone to mechanical
loading.
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Introduction
Normal remodeling of bone requires synchronized activity
between bone resorbing osteoclasts and bone forming osteoblasts,
as well as the coordination of this process by osteocytes, by far the
most abundant bone cell. An abundance of data generated over
the last several years suggest that connexins and gap junctional
intercellular communication (GJIC) play a critical role in
coordinating synchronized bone cell activity, especially in response
to extracellular signals including those induced by mechanical load
[1,2,3]. Gap junctions are membrane spanning channels that
allow passage of ions and signaling molecules, less than 1KD in
size, between two adjacent cells. Each gap junction is composed of
two hemi channels, or connexons, and each connexon is
comprised of 6 connexins. The predominant connexin (Cx) in
osteoblasts, osteoclasts and osteocytes is Cx43, but other connexins
have been identified in bone cells [4,5,6,7].
Most of the data supporting a role for Cx43 and GJIC in
osteoblastic cell differentiation, coordinated cell responsiveness,
and mechanotransduction comes from in vitro studies. For
instance, studies from our laboratory [8,9,10] and others
[11,12,13,14] demonstrated that Cx43 expression and GJIC
parallel osteoblastic differentiation and that inhibiting GJIC and
Cx43 expression in many osteoblastic cell lines and primary
cultures results in decreased expression of phenotypic character-
istics of differentiated osteoblasts. Additionally, Schiller et al [15]
showed that inhibiting GJIC induces the trans-differentiation of
osteoblastic MC3T3-E1 cells and primary culture human
osteoblastic cells to an adipocytic phenotype. In vivo studies
demonstrated that global knock out of Cx43 in mice results in
delayed skeletal ossification, craniofacial abnormalities, and
osteoblast dysfunction [16]. Additionally, mutations in the human
Cx43 gene lead to oculodentodigital dysplasia (ODDD) [17,18,19]
characterized by, among other things, skeletal dysplasia.
While these studies strongly suggest that Cx43 and GJIC are
critical to normal bone development and remodeling, they are
limited by their in vitro nature or the fact that they reflect the
consequence of global Cx43 deficiency during development only,
as global Cx43 deletion is embryonic lethal [20]. To address these
concerns, and examine the role of connexins in bone post
development, murine models of Cx43 conditionally deleted in only
osteoblasts and osteocytes have been developed [21,22]. However,
the bone phenotype described in these studies has been rather
inconsistent, with some models displaying an osteopenic pheno-
type in some studies [23] but not others [24] and other models not
displaying a basal bone phenotype at all [22].
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Cx43 gene in mouse osteoblasts and osteocytes using Cre
recombinase driven by the human osteocalcin promoter, as
previously reported by Plotkin et al [22], and evaluated the bone
phenotype. We found that osteoblast and osteocyte specific
ablation of Cx43 results in decreased bone mineral density
(BMD) and bone strength due at least in part to increased
osteoclastic activity. This increased osteoclastic activity is a result
of a decrease in Cx43 and GJIC that results in alterations in the
receptor activator of nuclear factor-kB-ligand)/osteoprotegerin
(RANKL/OPG) pathway in osteocytes but not osteoblasts.
Furthermore, in contrast to what previous in vitro studies
predicted, mice with osteoblast and osteocyte specific deletion of
Cx43 displayed an enhanced anabolic response to physiological
mechanical load.
Results
Generation of Osteoblast and osteocyte specific Cx43
deficient mice
Using the protocol described in Materials and Methods
(Figure 1A), we generated wild type equivalent (genotype:
Cx43
flx/flx, designated wild type), and conditional Cx43 deficient
equivalent (genotype: OC-Cre; Cx43
flx/flx, designated Cx43
deficient) mice.
The breeding strategy we used is more efficient for breeding
Cx43 deficient mice than the method used by Plotkin et al [22].
This strategy was previously used to ablate type I IGF receptor in
mouse osteoblasts and osteocytes [25]. These investigators
estimated the rate of OC-Cre ablation of ‘‘floxed’’ sequences in
osteoblasts and osteocytes to be approximately 88%.
Genotypes were determined by PCR as shown in Figure 1B
using the primers described in Table 1. A LacZ reporter gene was
inserted after Cx43
flx/flx, and deletion of Cx43 results in expression
of b-galactosidase [21]. Therefore, we examined X-gal staining in
osteoblastic cells isolated from femurs. Osteoblastic cells from
Cx43 deficient (Oc-Cre;Cx43
flx/flx) mice displayed positive X-gal
staining but osteoblastic cells from wild type (Cx43
flx/flx) mice did
not (Figure 2), demonstrating that Oc-cre expression resulted in
efficient deletion of the ‘floxed’ Cx43 alleles. To determine the
specificity of Cx43
flx deletion, we used primers (DelForw and
DelRev in Table 1) flanking the junction between the intron of the
Cx43 and LacZ coding region from the deleted allele to amplify
genomic DNA isolated from bones as well as other tissues. A
670 bp amplicon was obtained from DNA isolated from whole
femurs and calvaria of an Oc-Cre; Cx43
flx/flx mouse but was
absent from DNA extracted from soft tissues from the same mouse
(Figure 3). We also used the same DNA to amplify OC-Cre and
Cx43 as a control and detected an 865 bp Cre band and a 1KB
Cx43
flx band in all tissues examined (Figure 3). These data
(Figures 2 and 3) indicate that ‘‘floxed’’ Cx43 alleles were deleted
by OC-Cre in both osteoblasts and osteocytes.
Deletion of Cx43 reduced GJIC in osteoblasts
To determine whether deletion of Cx43 decreased GJIC in
bone cells, we isolated osteoblastic cells from femurs and tibias and
completed dual label dye transfer assays. GJIC was decreased
approximately 50% in osteoblastic cells isolated from Cx43
deficient mice relative to those isolated from wild type mice
(Figure 4). Cx45 and Cx26 mRNA levels were similar in wild type
and Cx43 deficient mice (data not shown). These data confirm
that the majority of GJIC communication in osteoblasts, as
assessed by dye transfer, is mediated by gap junctions composed of
Cx43.
Cx43 conditional deficient mice display decreased BMD
and have weaker bones
To examine the bone phenotype of Cx43 deficient and wild
type mice we examined 8 week and 6 month old male mice using
micro-computed tomography (mCT). mCT analysis of the midshaft
of the femur revealed periosteal and endosteal expansion in Cx43
deficient mice relative to wild type mice (Figure 5A). The femur
midshafts of 8 week old Cx43 deficient mice displayed statistically
significant 3.6% reductions in BMD (Figure 5B) and 24.7% and
35.4% increases in peri- and endosteal volume, respectively,
relative to wild type mice (Figure 5C and D). However, the cortical
bone thickness (Figure 5E) and porosity (Figure 5F) were not
significantly different. Femur midshafts from 6 month old Cx43
deficient mice also displayed significantly reduced BMD (4.1%)
and increased periosteal (29.6%) and endosteal volume (46.0%)
relative to wild type mice. However, cortical bone thickness and
porosity were not significantly different.
Femurs from 8 week old Cx43 deficient mice displayed a 35%
and 36% decrease in whole bone strength and material strength,
respectively, compared to wild type mice (Figure 6).
Cx43 deficiency increases bone formation rate
Since bone mass is balanced by bone formation and resorption,
we next examined, using dynamic histomorphometry and
quantification of a serum bone formation marker, whether the
phenotype in Cx43 deficient mice is due to decreased bone
formation. Eight week (Figure 7) and 6 month (Figure 8) old mice
ulna endocortical and periosteal bone mineral surface (MS/BS),
bone mineral apposition rate (MAR), and bone formation rate
(BFR/BS) were quantified. These three parameters were similar in
8 week old Cx43 deficient and wild type mice ulnae both at the
endosteal and periosteal surfaces. (Figure 7). However, significant
increases in endosteal MS/BS and BFR/BS, but not MAR, were
observed in 6 month old Cx43 deficient ulnae (Figures 8A, B and
C). No significant differences were detected in periosteal surfaces
Figure 1. Breeding of Cx43 deficient mice. A: Breeding strategy
for developing osteoblast and osteocyte Cx43 deficient mice and
assessment of their genotype. B: Using the primers described in Table 1,
genomic DNA extracted from ears was amplified for genotyping.
doi:10.1371/journal.pone.0023516.g001
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serum levels of the bone formation marker, procollagen I amino-
terminal propeptides (PINP) in the serum of 4 week old Cx43
deficient and wild type mice were similar (Figure 9). Taken
together these data suggest that bone formation was increased in
Cx43 deficient mice, relative to wild type mice, but this difference
did not reach statistical significance until the mice were older, i.e. 6
months.
Cx43 deficiency results in increased bone resorption and
osteoclastogenesis
Cx43 deficient mice displayed more TRAP positive cells than
did wild type mice in femur cortical and trabecular areas
(Figures 10A–D). We quantified osteoclast number in epiphyseal
trabecular bone of the femur and found that Cx43 deficient mice
displayed statistically significant increases in osteoclast number
compared to wild type (Figure 10E). Furthermore, serum Type I
collagen carboxyl-terminal crosslinking telopeptide (CTX) con-
centration, which is a product of collagen breakdown during
osteoclastic bone resorption, serum levels of which reflect degree of
bone resorption [26], increased approximately 1.5 fold in Cx43
deficient mice relative to wild type mice (Figure 10F). Taken
together these results suggest increased bone resorption and
osteoclastogenesis in Cx43 deficient mice.
Cx43 in osteocytic but not osteoblastic cells regulates the
RANKL and OPG mRNA level ratio
The RANKL-OPG axis is a major pathway through which
osteoblasts and osteocytes regulate osteoclastic bone resorption.
To examine the mechanism by which Cx43 deficiency in
osteoblasts and osteocytes leads to increased osteoclastogenesis
and bone resorption, we quantified the ratio of RANKL mRNA
levels to OPG mRNA levels (RANKL/OPG ratio), using real time
RT-PCR, in primary osteoblastic cells from Cx43 deficient and
wild type mouse long bones. Steady state Cx43 protein and
mRNA levels in osteoblastic cells from Cx43 deficient mice were
significantly decreased relative to levels in osteoblastic cells from
wild type mice, confirming Cx43 deficiency in Cx43 deficient mice
(Figures 11A and B). However, the RANKL/OPG mRNA ratio
was not significantly different in osteoblastic cells from Cx43
deficient and wild type mice (Figure 11C), which suggests that
ablation of Cx43 in osteoblasts does not affect osteoclastogenesis
through the RANKL-OPG pathway.
We next examined the RANKL/OPG mRNA ratio in
osteocytic cells. Because it is challenging to isolate homogeneous
populations of primary osteocytic cells, making interpretation of
results difficult, we used MLO-Y4 as model osteocytic cells. MLO-
Y4 cells were rendered Cx43 deficient by transfection with siRNA
directed against Cx43. As controls we examined MLO-Y4 cells
transfected with scrambled siRNA. We previously demonstrated
that MLO-Y4 cells transfected with Cx43 siRNA, identical to the
cells we used in this study, display significantly lower Cx43 protein
levels compared to MLO-Y4 cells transfected with scrambled
siRNA [59]. Transfection of Cx43 siRNA significantly reduced
Cx43 protein and mRNA levels in MLO-Y4 cells (Figure 11D and
E). Interestingly, Cx43 deficient MLOY-4 cells displayed a fivefold
increase in the RANKL/OPG mRNA ratio relative to scramble
control MLO-Y4 cells (Figure 10D). These data suggest that Cx43
Table 1. Primers used for genotyping.
Primer Sequence 59R39 Allele Length
Cre1 TGA TGG ACA TGT TCA GGG ATC Cre 865 bp
Cre2 CAG CCA CCA GCT TGC ATG A
UMP TCA TGC CCG GCA CAA GTG AGA C Cx43
flx and Cx43
+ 1 KB and 900 bp
UMPR TCA CCC CAA GCT GAC TCA ACCG9
43delforw GGC ATA CAG ACC CTT GGA CTC C Tissue specific deletion 670 bp
43delrev TGC GGG CCT CTT CGC TAT TAC G
doi:10.1371/journal.pone.0023516.t001
Figure 2. Confirmation of Cx43 deletion by X-gal staining. The
figure shows X-gal staining of osteoblasts isolated from femurs and tibia
of a wild type (Cx43
flx/flx, WT) and a Cx43 deficient (OC-Cre;Cx43
flx/flx,K O )
mouse. Cells from wild type mice had no blue staining indicating that
floxed Cx43 was not deleted in the absence of OC-Cre. Cells from a Cx43
deficient mouse were positive for b-galactodase indicating Cx43 deleted
by Cre.
doi:10.1371/journal.pone.0023516.g002
Figure 3. Confirmation of Cx43 deletion by PCR. The figure
shows PCR of genomic DNA extracted from bladder (bld), brain (brn),
calvaria (cal), heart (ht), humerus (hm), intestine (int), liver (lv), muscle
(msl), skin (sk), and spleen (spl) from a OC-Cre; Cx43
flx/+ mouse. DNA
was amplified using primers (Cx43delForw and Cx43delRev) flanking
the junction between the intron of Cx43 and LacZ region. If Oc-Cre is
activated the floxed Cx43 is deleted allowing amplification of a 670 bp
product. If Oc-Cre is not activated and floxed Cx43 is not deleted, the
template is too large to be amplified. We observed a 670 bp PCR
product in calvaria and humerus indicating Cx43 is deleted. The same
DNA was amplified using primers for Cre and Cx43 were used as
positive control.
doi:10.1371/journal.pone.0023516.g003
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via altering the RANKL/OPG mRNA ratio.
Ablation of Cx43 results in an enhanced response to
physiologic magnitude mechanical loading
At 6 months of age, tibiae of Cx43 deficient mice dispalyed
p.MS, p.MAR, and p.BFR values that were not statistically
significantly different than wild type mice (Figure 12). In wild type
mice, the mechanical loading regimen did not induce significant
increases in p.MS, p.MAR, or p.BFR compared to contralateral
tibiae. In contrast, mechanically loaded tibiae in Cx43 deficient
mice demonstrated significantly increased p.MS (132%,
p=0.003), and p.BFR (217%, p=0.001) compared with contra-
lateral tibiae (p.MAR was not significantly elevated). The 151%
greater p.BFR in the loaded tibiae of Cx43 deficient mice vs
loaded tibiae of wild type mice was primarily achieved via 222%
greater p.MS.
Figure 4. Quantification of GJIC in osteoblasts isolated from
wild type (WT) and Cx43 deficient (KO) mice. Donor hFOB cells
were placed in contact with a monolayer of acceptor cells isolated from
femurs from wild type or Cx43 deficient mice. Bars represent the
mean6SD number of acceptor cells to which dye transferred from each
donor hFOB cells. n=4 **p,0.01 vs wild type.
doi:10.1371/journal.pone.0023516.g004
Figure 5. Microstructure of the femur midshaft of wild type (WT) and Cx43 deficient mice (KO). mCT image of femoral midshaft of 8 week
old wild type (A left) and Cx43 deficient mice (A right) mice. Periosteal and endocortical expansion is evident in Cx43 deficient mice relative to wild
type. B–F: Quantification of mCT in 8 week old Cx43 deficient mice and wild type mice. Cx43 deficient mice displayed a significant decrease in BMD
(B) and increase in periosteal (C) and endocortical volumes (D). Cx43 deficient mice displayed no change in cortical bone thickness (E, p=0.054) or
bone porosity (F, p=0.55). n=9 mice per group, ** p,0.01, Bar=1 mm.
doi:10.1371/journal.pone.0023516.g005
Mechanical Load and Gap Junctions
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Emerging data suggest that Cx43 mediated GJIC is critical to
normal bone development. Unfortunately, examination of the role
of Cx43 post development is challenging because mice with global
Cx43 deficiency die at birth [16,20]. However, using a Collagen I
promoter controlled Cre and ‘‘floxed’’ Cx43 system, Chung et al
[23] reported that conditional ablation of Cx43 in only osteoblasts
and osteocytes resulted in decreased whole body BMD, as
determined by DEXA, decreased trabecular BV/TV, as deter-
mined by dynamic histomorphometry, and decreased osteoblastic
number, with no accompanying change in osteoclastic number.
Interestingly, in a subsequent study this group reported that the
same Cx43 deficient model displayed cortical thinning and
increased marrow size, relative to wild type, but no change in
site specific BMD or histomorphometric parameters [24]. Further
complicating the issue, Plotkin et al [22] reported that using an
osteocalcin promoter controlled Cre and floxed Cx43 system to
ablate Cx43 in osteoblasts and osteocytes, albeit at a later stage in
osteoblastic differentiation, did not result in changes in site specific
BMD as quantified by DEXA [22] None of the aforementioned
studies examined biomechanical strength of bone in Cx43
deficient mice. Thus, the role of connexins and GJIC in adult
bone metabolism remains unresolved.
To further address this issue we deleted Cx43 in osteoblasts and
osteocytes using the osteocalcin driven Cre and floxed approach
taken by Plotkin et al [22]. We demonstrated that deletion of Cx43
in bone cells significantly reduced GJIC confirming that Cx43 is
the predominant connexin in bone. However, unlike the studies of
Plotkin et al, our data showed that specific deletion of Cx43 in
osteoblasts/osteocytes leads to a phenotype that includes de-
creased BMD and, importantly, decreased mechanical strength
(Figures 5 and 6). Furthermore, whereas Chung et al and
Grimston et al did not detect a significant change in histomor-
phometric parameters we detected a moderate increase in both
endosteal and periosteal MAR and BFR/BS in 8 week old Cx43
deficient mice ulnae (Figure 7) and a statistically significant
increase in MAR and BFR/BS in 6 month old Cx43 deficient
mouse ulnae relative to wild type control mice (Figure 8).
One possible explanation as to why our results differ from those
previously reported is that we used mCT and dynamic histomor-
phometry to access overall adult bone morphology, as well as bone
formation and resorption, whereas previous studies used DEXA
alone or DEXA combined with dynamic histomorphometry,
which may be less sensitive approaches than mCT. Furthermore,
in the case of the murine model developed by Chung et al [23] and
Grimston et al [24], Cx43 deficiency was driven by the Collagen 1
promoter and therefore occurred at an earlier point in osteoblastic
differentiation relative to the model we used, wherein the Cx43
deficiency is driven by the osteocalcin promoter and therefore
occurs later in osteoblastic differentiation. This difference could
account for some of the differences in phenotype between the
models. In any case, our finding of decreased mechanical strength
and increased markers of osteoclastic bone resorption in Cx43
deficient mice, relative to wild type, when combined with our mCT
and histomorphometric data, strongly suggest an osteopenic
phenotype in mice with Cx43 deficient osteoblasts and osteocytes.
Since deleting Cx43 in osteoblasts and osteocytes did not affect
mouse ambulation (data not shown), our data indicate that
functional Cx43 in osteoblasts and osteocytes is required for
normal bone mass acquisition and maintenance. Our finding that
MAR and BFR are not reduced, and if anything are increased, in
Cx43 deficient mice, together with those of Plotkin, Chung and
Figure 7. Dynamic histomorphometry in 8 week old mice. Eight week old Cx43 deficient (KO) and wild type (WT) mice displayed similar
endocortical or periosteal mineralized surface (MS/BS, A, D) bone mineral apposition rates (MAR, B, E) and bone formation rates (BFR/BS, C, F). n=6
mice per group.
doi:10.1371/journal.pone.0023516.g007
Figure 6. Strength of femurs from 8 week old mice. Femurs were
loaded to failure using 3-point bending and maximum tensile stress at
failure was determined form force deformation curves. Both load (left)
and stress (right) at failure were significantly lower in Cx43 deficient
mice (KO) relative to wild type (WT) mice. n=6–7 mice per group,
*p,0.05 vs wild type.
doi:10.1371/journal.pone.0023516.g006
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in a similar mouse model, suggests that a decrease in osteoblastic
activity does not contribute to the bone phenotype we observed in
osteoblast and osteocyte specific Cx43 deficient mice.
Because our data suggest that decreased osteoblastic function
was not mediating the cortical bone phenotype in Cx43 deficient
mice we examined another possible explanation, increased
osteoclastic bone resorption. Interestingly, TRAP staining revealed
that Cx43 deficient mice have more osteoclasts than wild type
mice (Figure 10A–E). Cx43 deficient mice also displayed increased
serum levels of the bone resorption marker CTX (Figure 10F), but
no significant change in levels of the bone formation marker PINP,
relative to wild type mice (Figure 9). These data suggest that
ablation of Cx43 in mouse bone cells leads to decreased BMD and
weakened bones due to increased bone resorption.
We next sought to determine how Cx43 deficiency could result
in increased osteoclast differentiation or activity. A major regulator
of osteoclast formation and activity is the RANKL/OPG system.
RANKL, a ligand expressed on the surface of marrow stromal
cells and osteoblastic precursors, binds to its receptor found on the
surface of osteoclastic precursor cells and thereby activates
osteoclastogenesis. OPG serves as a soluble decoy molecule and
binds with RANKL thus blocking its activity and inhibiting
osteoclastogenesis. The ratio of RANKL to OPG, therefore,
provides a reliable indicator of relative osteoclastogenesis.
However, we found the RANKL/OPG mRNA ratio in osteo-
blastic cells isolated from Cx43 deficient mice was similar to that in
osteoblastic cells isolated from wild type mice. Therefore, it is
unlikely that Cx43 regulation of the RANKL/OPG pathway in
osteoblastic cells contributed to altered osteoclastogenesis.
We next examined whether Cx43 deficiency in osteocytic cells
could alter the RANKL/OPG ratio and thereby contribute to
decreased osteoclastogenesis. Osteocytes are the most abundant
cells in bone [27] and are well coupled with each other and
osteoblasts via GJIC [28,29,30] and GJ are the key couplers in the
osteocyte syncytium [31,32]. Osteocytes regulate bone formation
by mediating, via GJIC, the effects of mechanical load on
osteoblastic differentiation [33]; through the release of osteoblast
activating factors including nitric oxide [34] and prostaglandins
[35]; and by modulation of Wnt/b-catenin signaling [36].
Osteocytes can also regulate bone resorption [37]. Targeted
ablation of osteocytes in vivo results in increased RANKL/OPG
expression ratios, increased osteoclast number and osteopenia
[38]. Furthermore, osteocyte-like MLO-Y4 cells express RANKL
and induce osteoclast formation and activation [39] and You et al
showed that exposure to fluid flow inhibits MLO-Y4 induced
osteoclastic bone resorption via decreasing the RANKL/OPG
ratio [40]. Interestingly, we have previously demonstrated that
fluid flow similar to that examined by You et al [40] also increases
Cx43 expression and phosphorylation [41], indirectly linking
Cx43 activity with the RANKL/OPG pathway. Taken together
these data suggest that Cx43 deficiency may affect the osteocytic
RANKL/OPG ratio in osteocytes. In strong support of this
concept, using MLO-Y4 osteocytic cells as a model, our data
demonstrate that Cx43 deficient osteocytic cells display an
increased RANKL/OPG mRNA ratio (Figure 11F) which may
explain the increased osteoclastogenesis and increased bone
resorption we observed in Cx43 deficient mice. This is the first
direct evidence of a link between connexins and the RANKL/
OPG pathway. It is unlikely that the regulation by Cx43 and GJs
of the RANKL/OPG pathway is related to the heterotypic GJIC
Figure 9. Quantification of serum markers of bone formation.
Four week old Cx43 deficient (KO) and wild type (WT) control mice have
similar PINP concentrations in serum. n=3–9 mice per group.
doi:10.1371/journal.pone.0023516.g009
Figure 8. Dynamic histomorphometry in 6 month old mice. Six month old Cx43 deficient (KO) mice show significantly increased endocortical
MS/BS (A), and BFR (C), but no significant change in other parameters (B, D, E and F). n=4–5 mice per group, ** p,0.01.
doi:10.1371/journal.pone.0023516.g008
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occurred in MLO-Y4 in mono culture in the absence of
osteoclasts. However, this does not preclude a role for homotypic
GJIC between MLO-Y4 cells in the regulation of the RANKL/
OPG pathway.
The mechanism by which Cx43 and GJIC interacts with the
RANKL/OPG pathway is unclear. However, published reports
suggest that the activity of SP-1/SP-3 transcription factors is
regulated by Cx43 mediated GJIC in osteoblastic cells [42,43] and
SP1 an SP3 are implicated in the regulation of both RANKL and
OPG gene expression [44,45,46]. Therefore, Cx43 and GJIC
regulation of RANKL and OPG could be mediated by effects on
SP1, SP3, or both.
Emerging data suggest that Cx43 and GJIC contribute to
mechanotransduction in bone [41,47]. For instance, cyclic stretch
has been shown to increase Cx43 protein expression and GJIC in
osteoblastic cells in vitro [47], and we [41] and others [1,48,49]
demonstrated that fluid flow increases GJ expression and function
in osteocytic MLO-Y4 cells. Additionally, GJs communicate
mechanical signals detected by osteocytic MLO-Y4 cells to
osteoblastic cells thereby increasing osteoblastic differentiation
[33]. In vivo, Lozupone et al [50] demonstrated that mechanical
loading of rat metatarsal bones increased the incidence of
osteocytic GJs and we demonstrated that expression of Cx43 by
osteocytes is increased in areas of bone exposed to tension relative
to areas exposed to compression or to control bone [51].
Interestingly, we also demonstrated that GJIC deficient bone cells
are dramatically less responsive to parathyroid hormone [10], fluid
flow [2,52] and electric fields [53] than are normal osteoblastic
cells. Thus, in vitro GJIC contributes to the responsiveness of
osteoblastic cells to diverse extracellular signals, including those
that are believed to mediate the anabolic effects of mechanical
load. In this context one might predict that bone with Cx43
deficient osteoblasts and osteocytes would be less responsive to the
anabolic effects of mechanical load. Indeed, using a Collagen I
promoter controlled Cre and ‘‘floxed’’ Cx43 deficient mouse
model and three point bending, Grimston et al reported that
increased endocortical BFR and MAR in response to mechanical
load was attenuated in osteoblast and osteocyte specific Cx43
deficient, relative to wild type, mice [24].
In contrast, our in vivo mechanical loading data clearly
demonstrate that deletion of Cx43 in osteoblasts and osteocytes
results in an enhanced periosteal response to physiological
mechanical loading. That these data contrast with those of
Grimston et al may be due to differences in basal levels of
periosteal osteoblast function, magnitude of induced strains (low
level osteogenic stimulus in the current study versus a stimulus
sufficient to induce periosteal woven bone formation in the study
by Grimston et al [24]) and differences in mechanotransduction at
the periosteal versus endocortical surface. Furthermore, our
loading studies were completed on 6 month old mice, a period
at which peak bone mass was attained, while the studies by
Grimston et al [24], were completed on 4 month old mice. In any
case, we believe our data are internally consistent with the cortical
bone phenotype of Cx43 deficient mice (i.e., an expanded
periosteal envelope) which reflects an accumulation of elevated
Figure 10. Cx43 deficient mice display increased bone resorption and osteoclast number. Four week old Cx43 deficient mice show
increased osteoclast number in the distal epiphyseal area (A) and increased serum CTX concentration (B). n=4 (A) or 3–9 (B) mice per group,
*p ,0.05. C–E: Typical TRAP staining of four-week old wild type (WT) (C and D) and Cx43 deficient (KO) (E and F) mouse femur. There are more
osteoclasts in bone from Cx43 deficient mice. Scale bar=100 mm.
doi:10.1371/journal.pone.0023516.g010
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enhanced response to loading was achieved at the level of the
osteocyte or osteoblast (or both).
In their entirety, we believe these data provocatively suggest that
gap junctions composed of Cx43 may serve, in vivo, as conduits
for intercellular signaling that inhibits osteoblastic activity at the
periosteal surface and osteoclastic activity at the endocortical
surface. Thus, eliminating Cx43 and GJIC results in increased
osteoblastic and osteoclastic activity, as evidenced by accelerated
cortical expansion. While the mechanism of increased osteoblastic
activity is unclear the increased osteoclastic activity is a result of an
increase in the RANKL/OPG ratio. Inhibition of Cx43 expression
would then result in both increased osteoblastic bone formation
and an even greater unbalanced increase in osteoclastic bone
resorption, resulting in a phenotype characterized by decreased
BMD and weaker bones. Exposing Cx43 deficient mice to
mechanical load may decrease the osteocytic RANKL/OPG
ratio, as suggested by in vitro studies [40], thus decreasing
Figure 11. Ablation of Cx43 affects RANKL/OPG mRNA ratio in osteocytic but not osteoblastic cells. Cx43 protein (A) and mRNA (B)
levels in primary osteoblasts from Cx43 deficient (KO) mice were decreased relative to wild type (WT), but the ratio of RANKL/OPG mRNA levels were
similar in osteoblasts from Cx43 deficient and wild type mice (C). Osteocytic MLO-Y4 cells were transfected with either scrambled control siRNA or
siRNA directed against Cx43 mRNA. MLO-Y4 cells transfected with Cx43 siRNA displayed decreased Cx43 protein (D) and mRNA levels (E) but
increased RANKL/OPG mRNA levels (F), relative to cells transfected with control siRNA. n=3 separate experiments for A and D; 11–12 for B and C;
and 10 for E and F), ** p,0.01.
doi:10.1371/journal.pone.0023516.g011
Figure 12. Mechanical loading of bone in Cx43 deficient and wild type mice. An enhanced periosteal osteoblastic response was observed in
6 month old Cx43 deficient mice (KO) relative to wild type (WT) when the right tibias of each were exposed to mechanical loading that induced
equivalent peak normal strains. p.MS, p.MAR and p.BFR are reported for contralateral (C) and loaded tibias (L). p.MS and p.BFR were significantly
greater in loaded tibia, relative to contralateral, in Cx43 deficient mice but not wild type mice. p.Mar in loaded tibia was not significantly different
than in contralateral tibia in Cx43 deficient or wild type mice. n=7–9 mice per group, * p,0.05.
doi:10.1371/journal.pone.0023516.g012
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activity. This would explain the increased anabolic response to
mechanical load in Cx43 deficient mice. Additionally or
alternatively, the increased osteoblastic activity at the periosteal
surface may account for the increased anabolic response to
mechanical load.
In summary, our data suggest that deletion of Cx43 in
osteoblasts and osteocytes leads to decreased BMD and weaker
bones. In vitro studies suggest that this phenotype may, at least
partly, be a result of an incrased RANKL/OPG ratio in
osteocytes, but not osteoblasts, resulting in increased osteoclast
formation. Importantly, Cx43 deficient mice display an enhanced
bone anabolic response to mechanical loading. Thus, transient
inhibition of connexin expression and GJIC may prove a
potentially powerful means of enhancing bone’s anabolic response
to mechanical loading.
Materials and Methods
Transgenic mice
Mice expressing Cre recombinase under the control of the
human osteocalcin promoter (abbreviated as OC-Cre; Cx43
+/+)
[25] were first bred with mice in which the Cx43 gene is flanked
by two loxP sites (Cx43
flx/flx) [21] to generate OC-Cre; Cx43
flx/+
mice. Next, we crossed OC-Cre; Cx43
flx/+ with Cx43
flx/flx to
generate OC-Cre; Cx43
flx/flx. We then back bred OC-Cre;
Cx43
flx/flx mice with Cx43
flx/flx mice to generate equal number
of OC-Cre; Cx43
flx/flx (Cx43 deficient equivalent) and Cx43
flx/flx
(wild type) littermate mice. Mice derived from this breeding
strategy were bred with C57BL/6 for 3 generations resulting in
mice with a C57BL/6 background. Genotyping was performed by
PCR using genomic DNA isolated from mouse ear pieces and
primers listed in Table 1. To test the specificity of Cx43 ablation,
DNA was isolated from bladder, brain, calvaria, heart, humerus,
intestine, liver, muscle, skin, and spleen using a Qiagen DNeasy
Tissue Kit (Qiagen) and amplified with Cx43delForw and
Cx43delRev primers (Table 1). Soft tissue and marrow were
removed before DNA was isolated from calvaria and humerus.
The DNA from calvaria and humerus should contain DNA from
both osteoblasts and osteocytes. All animal work was conducted
according to relevant national and international guidelines and
was approved under Penn State College of Medicine’s IACUC
protocol #94-120.
Cell culture
Two cell lines were used in this study. The immortalized
osteocytic cell line MLO-Y4, (kindly provided by Dr. Lynda
Bonewald), was cultured on type I collagen (BD Laboratory)
coated plates in Modified Eagle Medium Alpha (aMEM, GIBCO)
supplemented with 5% fetal bovine serum (FBS), 5% calf serum
(CS), and 1% penicillin and streptomycin (P/S). The human fetal
osteoblastic progenitor cell line hFOB 1.19 cells (kindly provided
by Dr. Steven Harris) was maintained using Dulbecco’s modified
Eagle’s medium (DMEM)–Ham’s F-12 1:1 media (GIBCO)
supplemented with 10% FBS and 1% P/S.
Primary osteoblastic cells were isolated from explant cultures of
3 week old Cx43 deficient or wild type femurs and tibias which
were digested in 1 mg/mL collagenase (Sigma, St Louis, MO) for
75–120 min at 37uC in a shaking water bath. The bones were cut
into small pieces and the pieces from one femur and one tibia
placed into one well of a 6 well plate in 600 mLo faMEM, with
10% FBS, 1%PS, 1% antimycotic (Sigma, St Louis, MO), 50 mg/
mL ascorbic acid phosphate (Wako, Richmond, VA) for 5 days.
The media was replaced with fresh media without antibiotics for
one week. Cells that grew out from the bone fragments were then
sub-cultured into 100 mm dishes. When the cells were 90%
confluent gap junctional communication, protein and mRNA
levels were quantified.
Quantification of gap junctional intercellular
communication
GJIC was quantified using a dual label fluorescent dye transfer
technique and flow cytometry as previously described [54]. Donor
hFOB cells were labeled with a fluorescent dye mixture containing
20 ml of calcein AM and 7 ml of 1,19-dioctadecyl-3,3,39,39-
tetramethylindolcarbocyanine perchlorate (DiI) (Molecular
Probes, Eugene, OR) in 2 mL of bovine serum albumin-enriched
phosphate buffered saline (PBS) with 20 ml of pluronic acid
(Molecular Probes). Five thousand hFOB donor cells were
dropped into one well of a 6 well plate covered with a monolayer
of unlabeled acceptor osteoblasts from femurs and tibias of wild
type or Cx43 deficient mice and incubated for 90 min at 37uC.
Cells were released with trypsin and analyzed via fluorescence-
activated cell sorter analysis (FACS; FACScan; BD-Pharmingen)
as previously described [33]. Briefly, transfer of cytosolic calcein
from hFOB donors to murine acceptor osteoblastic cells was
quantified by analyzing the number of cells falling within the
‘‘acceptor’’ gate. The acceptor gate was determined using
fluorescence intensity and set to exclude 99% of negative cells
and 99.25% of donors.
mCT to assess bone microstructure
Femurs from the right side of 8 week and 6 month old mice were
harvested for mCT analysis. The diaphyses were scanned starting at
the midpoint of the bone and acquiring 76 slices distally using a
Scanco vivaCT 40 (Scanco Medical AG, Bru ¨ttisellen Switzerland)
with scan settings of 55 KVp, 145 mA, and 200 ms integration time.
Images were reconstructed as a matrix of 204862048676 isotropic
voxels measuring 10.5 mm. Images were gaussian filtered (sig-
ma=0.8, support=1) and a threshold (24% of full scale) was
applied to remove the surrounding soft tissue. The periosteal and
endosteal boundaries of the cortical bone were segmented using the
Scanco semi-automated edge detection algorithm. Periosteal
volume, endosteal volume, bone porosity, cortical bone thickness,
and BMD were calculated for the diaphysis of each femur using the
Scanco Image Processing Library routines.
Bone mechanical testing
Femurs from 8 week old mice were stored in PBS at 280uC
before being mechanically tested to failure in three-point bending
using an MTS MiniBionix 858 testing apparatus (MTS Systems,
Eden Prairie, MN, USA) [55]. The flexural support spans were
8 mm while a loading rate of 1 mm/minute was applied. Femurs
were consistently oriented so that loading occurred in the medial
to lateral direction. All testing was executed with the bones
hydrated and at ambient temperature.
Material property calculation
Using the midshaft mCT image to calculate the moment of
inertia, the ultimate tensile stress was calculated using Euler-
Bernoulli beam theory. The ultimate tensile stress was calculated
using the flexural formula (stress=FLc/4I), where F is the ultimate
load, L is the support span length, c is the perpendicular distance
from the neutral axis to the most lateral point on the bone surface,
and I is the bending moment of inertia calculated about the
neutral axis.
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For examination of 8 week and 6 month old mice, male mice
were given an intraperitoneal injection of calcein (Sigma) at
10 mg/kg body weight and 6 days later injected with Alizarin
red (Sigma) at 30 mg/kg body weight. Seven days after the
second injection mice were sacrificed and ulnae were dissected
and embedded using an Osteo-Bed bone embedding kit
(Polysciences, Warrington, PA) following the manufacturer’s
protocol. The embedded ulnae midshafts were then cut into
approximately 100 mm thick discs followed by abrasive polishing
to a thickness of about 50 mm with lapping films (3 M, St. Paul,
MN). Digital images were obtained using a confocal microscope
(Leica, Bannockburn, IL). The following periosteal and end-
cortical bone parameters were quantified with ImageJ (NIH,
Bethesda, MD): total perimeter (B.Pm); single label perimeter
(sL.Pm); double label perimeter (dL.Pm), and double label area
(dL.Ar). The following values were then calculated: mineralizing
surface (MS/BS=[1/2sL.Pm+dL.Pm]/B.Pm6100; %); mineral
apposition rate (MAR=dL.Ar/dL.Pm/6 days; mm/day) and
bone formation rate (BFR/BS=MAR6MS/BS63.65; mm
3/mm
2
per year) [56].
Quantification of mouse serum bone formation and
resorption markers
Serum was collected from 4 week old mice fasted for 8 hours.
Type I collagen N-terminal propeptide (PINP) and C-terminal
telopeptides (CTX) were measured with EIA or ELISA kits from
Immunodiagnostic Systems Inc (IDS, Fountain Hills, AZ)
according to manufacturer’s protocols.
Histological identification of osteoclasts
Right femurs from 6 month old mice were fixed in 4%
paraformaldehyde for 3 days prior to decalcification with 10%
EDTA (pH 7.4) for 5 days. These specimens were embedded in
paraffin and cut into 5 mm sections then subjected to TRAP
staining using a technique modified from Erlebacher and
Derynck [57]. Briefly, femoral sections were de-waxed in xylene
and rehydrated in ethanol and water. After equilibration in
0.2 M sodium acetate and 50 mM sodium tartrate, pH 5.0, for
20 min at room temperature, sections were incubated at 37uCi n
the same buffer containing 0.5 mg/mL naphthol AS-MX
phosphate (Sigma, St Louis, MO) and 1.1 mg/mL Fast Red
TR salt (Sigma, St Louis, MO) for 40 min, or until osteoclasts
were bright red. Sections were then counterstained in methyl
green (Sigma, St Louis, MO). Stained sections were observed
under a microscope and TRAP positive cells with three or more
nuclei were counted as osteoclastic cells. Femur distal epiphyseal
osteoclasts were quantified by using a method modified from
Sawyer et al [58].
siRNA transfection and quantification of protein and
mRNA levels
Osteocytic MLO-Y4 cells were transfected with either Cx43 or
scramble control siRNA as previously described [59]. Forty-eight
hours after transfection, protein and total RNA was collected.
Cx43 protein level was quantified by western blot analysis as
previously described [60], except Cx43 antibody (Sigma, 1:8000
dilution) was used. Cx43, RANKL and OPG mRNA levels were
assessed, by real-time RT-PCR [61], in MLO-Y4 cells treated
with either Cx43 siRNA, or scramble control, and in primary
osteoblasts from wild type and Cx43 deficient mice.
In vivo mechanical loading
Initial studies indicated that Cx43 deficient mice demonstrated
an osteopenic cortical bone phenotype with expanded endocor-
tical and periosteal surfaces compared to wild type littermates.
This morphology suggests an accumulation of elevated periosteal
osteoblast function and elevated endocortical osteoclast function
through development. We confirmed this morphologic phenotype
in 17 week old mice via high resolution mCT. Concurrent bone
labeling indicated that the periosteal surface was highly active in
the majority of Cx43 deficient mice at this age.
As an active periosteum has the potential to confound
assessment of bone’s response to physiologic loading [62], we
initiated the loading protocol when mice were 6 months of age. At
this time, dynamic histomorphometry of sentinel mice indicated
minimal baseline periosteal bone formation rate (p.BFR) in both
Cx43 deficient and wild type mice. Three days prior to initiation
of the loading protocol, the right tibia mid-diaphysis of all mice
were imaged via high resolution mCT (Scanco vivaCT40) and
custom algorithms were used to develop animal specific estimates
for normal strains induced by our non-invasive tibia loading device
[63]. We altered applied end loads such that peak induced
compressive normal strains at the tibia mid-shaft in Cx43 deficient
mice (n=7; 1300690 mstrain) were not statistically different than
those of wild type mice (n=7; 1275690 mstrain p=0.83). Each
mouse underwent a 3 week, 3 day/week loading intervention, in
which the mouse was anesthetized, the right tibia placed in the
loading device, and the tibia loaded for 100 cycles per bout at
1 Hz. calcein labels were injected on day 10 and 19, and following
sacrifice on day 21, mid-shaft cross-sections from left (contralat-
eral) and right (experimental) tibiae were processed for dynamic
histomorphometry. As we equilibrated exogenously induced
strains on the periosteal surface, we confined our analysis to that
surface. Mineralizing surface (p.MS), mineral apposition rate
(p.MAR) and bone formation rate (p.BFR) were quantified using
standard techniques.
Statistical Analyses
Data are expressed as means 6 SD. Statistical significance was
assessed by Student’s t-test when comparing two groups. One way
ANOVA was used to assess multiple group comparisons and a
Tukey post-hoc test to assess differences between groups. p,0.05
was considered significant.
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